CARv3-TEAM-E T-cell treatment beneficial for recurrent glioblastoma
by Elana GotkineFor patients with recurrent glioblastoma, treatment with chimeric antigen receptor (CAR) T-cells engineered to target the epidermal growth factor receptor (EGFR) variant III tumor-spec
Updated on: March 27,2024
0
CARv3-TEAM-E T-cell treatment beneficial for recurrent glioblastoma
by Elana GotkineFor patients with recurrent glioblastoma, treatment with chimeric antigen receptor (CAR) T-cells engineered to target the epidermal growth factor receptor (EGFR) variant III tumor-spec
Updated on:March 27,2024
0